Long-term study of zuranolone for postpartum depression symptoms
Treatments studied
Part of Mental health, Women’s health & pregnancy clinical trials.
This study checks how people with postpartum depression feel over time after starting zuranolone. It uses simple questionnaires to track changes in symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a prescription for zuranolone from Accredo Specialty Pharmacy.
- You gave birth or had a pregnancy in the last 12 months.
- You have been diagnosed with postpartum depression.
- You can fill out questionnaires in English by yourself.
- You haven't taken zuranolone or brexanolone in the past 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications, quetiapine and trazodone, to see which works better for women with postpartum depression. You take one of them for about 8 weeks, and the team checks your mood and side effects.
This trial studies a treatment aimed at improving maternal mental health during pregnancy. It focuses on people who have had depression around pregnancy before, and checks whether the approach is safe and helpful for them.
This study looks at mothers’ well-being after having a baby, to understand what affects mental and emotional health after childbirth. It may help improve support for mothers during the postnatal period.
This study looks at how the medicine zuranolone (taken for postpartum depression) works in real life for people who got a prescription within a year after their pregnancy ended. Researchers want to see if symptoms improve and how participants feel while taking it.
This trial tests whether allopregnanolone, a natural brain chemical, can help depression in women going through menopause. It compares the effects against a placebo to see if it improves mood symptoms.
This trial tests a new medicine called zuranolone (allopregnanolone) for people with depression after a stroke. It aims to see if the drug can help improve mood when taken over a short period.
Hear when a new Postpartum Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.